IL-6 during viral-induced chronic autoimmune myocarditis: Is it protective or pathogenic?

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 318-325

  Poffenberger, Maya C ^a   Horwitz, Marc S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Coxsackievirus; Interleukin 6; Myocarditis; Th17

Indexed keywords

INTERLEUKIN 6;

ANIMAL CELL CULTURE; AUTOIMMUNE DISEASE; AUTOIMMUNE MYOCARDITIS; CHRONIC DISEASE; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; PATHOGENICITY; T LYMPHOCYTE; VIRUS MYOCARDITIS;

COXSACKIEVIRUS;

EID: 69949138556     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04850.x     Document Type: Conference Paper

References (36)

1. Kuhl, U. et al. 2005. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970.
2. Cunningham, C. & C.H. Lee. 2003. Myocarditis related to Campylobacter jejuni infection: a case report. BMC Infect. Dis. 3: 16.
3. Odeh, M. & A. Oliven. 1992. Chlamydial infections of the heart. Eur. J. Clin. Microbiol. Infect. Dis. 11: 885-893.
4. LeLeiko, R.M., D.J. Bower & C.P. Larsen. 2008. MRSA-associated bacterial myocarditis causing ruptured ventricle and tamponade. Cardiology 111: 188-190.
5. Felker, G.M. et al. 1999. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1, 278 patients. Medicine (Baltimore) 78: 270-283.
6. Fairweather, D. & N.R. Rose. 2007. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118-122.
7. Rose, N.R. et al. 1987. Cardiac myosin and autoimmune myocarditis. Ciba Found Symp. 129: 3-24.
8. Wolfgram, L.J. et al. 1986. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J. Immunol. 136: 1846-1852.
9. Kishimoto, C. et al. 2003. An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency mouse. Cardiovasc. Res. 60: 397-403.
10. Eriksson, U. et al. 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9: 1484-1490.
11. Fairweather D. & N.R. Rose. 2005. Inflammatory heart disease: a role for cytokines. Lupus 14: 646-651.
12. Horwitz, M.S. et al. 2006. Transforming growth factor-beta inhibits coxsackievirus-mediated autoimmune myocarditis. Viral Immunol. 19: 722-733.
13. Lane, J.R. et al. 1992. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J. Exp. Med. 175: 1123-1129.
14. Kanda, T. & T. Takahashi. 2004. Interleukin-6 and cardiovascular diseases. Jpn. Heart J. 45: 183-193.
15. Richer, M.J. et al. 2006. Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus- mediated autoimmune myocarditis. Clin. Immunol. 121: 339-349.
16. Samoilova, E.B. et al. 1998. IL-6-deficient mice are resistant to experimental autoimmune en-cephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161: 6480-6486.
17. Richards H.B. et al. 1998. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188: 985-990.
18. Alonzi, T. et al. 1998. Interleukin 6 is required for the development of collagen-induced arthritis. J. E x p. Med. 187: 461-468.
19. Deng, C. et al. 2002. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. J. Immunol. 169: 1077-1083.
20. Korn, T. et al. 2007. Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19: 362-371.
21. Bettelli, E., T. Korn & V.K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19: 652-657.
22. Pasare C. & R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
23. Eriksson U. et al. 2003. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 107: 320-325.
24. Sonderegger, I. et al. 2006. Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol. 36: 2849-2856.
25. Rangachari, M. et al. 2006. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 203: 2009-2019.
26. Valaperti, A. et al. 2008. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 180: 2686-2695.
27. Sonderegger I. et al. 2008. GM-CSF mediates au-toimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205: 2281-2294.
28. Frohlich, A. et al. 2007. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109: 2023-2031.
29. Sonderegger, I. et al. 2008. IL-21 and IL-21R are not required for development of Th17 cells and autoim-munity in vivo. Eur. J. Immunol. 38: 1833-1838.
30. Kanda T. et al. 1996. Modification of viral myocarditis in mice by interleukin-6. Circ. Res. 78: 848-856.
31. Tanaka, T. et al. 2001. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha. J. Mol. Cell. Cardiol. 33: 1627-1635.
32. Fairweather, D. et al. 2005. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J. Immunol. 174: 261-269.
33. Rose N.R. 2008. Autoimmunity in coxsackievirus infection. Curr. Top. Microbiol. Immunol. 323: 293-314.
34. Li, H.S., D.L. Ligons & N.R. Rose. 2008. Genetic complexity of autoimmune myocarditis. Autoimmun. Rev. 7: 168-173.
35. Oukka, M. 2008. Th17 cells in immunity and au-toimmunity. Ann. Rheum. Dis. 67(Suppl 3): iii26-iii29.
36. Esfandiarei, M. & B.M. McManus. 2008. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 3: 127-155.